EXPLORING THE POTENTIAL BUDGET IMPACT OF EMICIZUMAB FOR HEMOPHILIA A WITH INHIBITOR IN ITALY

被引：0
|
作者：
Cortesi, P. A. [1 ]
D'Angiolella, L. S. [1 ]
Ferrario, M. [2 ]
Cesana, G. [1 ]
Mantovani, L. G. [1 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Roche SpA, Monza, Italy
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2619
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY42
引用
收藏
页码：S442 / S443
页数：3
相关论文
共 50 条
  • [31] Non-inhibitory antibodies inducing increased emicizumab clearance in a severe hemophilia A inhibitor patient
    Harroche, Annie
    Sefiane, Thibaud
    Desvages, Maximilien
    Borgel, Delphine
    Lasne, Dominique
    Casari, Caterina
    Peyron, Ivan
    Frenzel, Laurent
    Chhun, Stephanie
    Lenting, Peter J.
    Bally, Cecile
    [J]. HAEMATOLOGICA, 2021, 106 (08) : 2287 - 2290
  • [32] Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors
    Cortesi, Paolo Angelo
    Castaman, Giancarlo
    Trifiro, Gianluca
    Creazzola, Simona Serao
    Improta, Giovanni
    Mazzaglia, Giampiero
    Molinari, Angelo Claudio
    Mantovani, Lorenzo Giovanni
    [J]. THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 216 - 228
  • [33] Central Line-Associated Thrombus Formation in an Inhibitor Negative Severe Hemophilia A Patient on Emicizumab
    George, Nicholas B.
    Paschke, Alexander
    Scott, Katie
    [J]. BLOOD, 2019, 134
  • [34] PERI-OPERATIVE ORTHOPEDIC MANAGEMENT OF A PATIENT WITH SEVERE HEMOPHILIA A AND A FACTOR VIII INHIBITOR ON EMICIZUMAB
    Rupani, Natasha S.
    Khalife, Roy
    Tinmouth, Alan
    Ward, Sarah
    Sholzberg, Michelle
    Teitel, Jerry
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E93 - E93
  • [35] The impact on nursing care for Hemophilia A Patients with inhibitors in Quebec: conventional therapies vs Emicizumab
    Meilleur, Claude
    Neron, Helene
    [J]. HAEMOPHILIA, 2020, 26 : 117 - 117
  • [36] Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report
    Kawahara, Fuko
    Shirayama, Rie
    Ito, Takuma
    Oshida, Koichi
    Sato, Tetsuji
    Kusuhara, Koichi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (06) : 906 - 912
  • [37] Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer
    Sirachainan, Nongnuch
    Chuansumrit, Ampaiwan
    Parapakpenjune, Surapan
    Wongwerawattanakoon, Pakawan
    Lertthammakiat, Surapong
    Kadegasem, Praguywan
    Sasanakul, Werasak
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [38] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS
    Cortesi, P. A.
    Castaman, G.
    Trifiro, G.
    Ferrario, M.
    Improta, G.
    Mazzaglia, G.
    Molinari, A. C.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2019, 22 : S845 - S845
  • [39] Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis
    Shimonishi, Naruto
    Sasai, Kana
    Ogiwara, Kenichi
    Furukawa, Shoko
    Nakajima, Yuto
    Mizumachi, Kuniyoshi
    Yada, Koji
    Takeyama, Masahiro
    Shima, Midori
    Mizuno, Narumi
    Nogami, Keiji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (06) : 690 - 698
  • [40] BUDGET IMPACT OF FACTOR VIII TREATMENTS FOR HEMOPHILIA A IN THE UNITED STATES
    Fan, Q.
    Carter, J. A.
    Mokdad, A. G.
    Caicedo, J.
    Bullano, M.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S73 - S73
12345